We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$712B
AUM Growth
+$77.7B
Cap. Flow
+$6.45B
Cap. Flow %
0.91%
Top 10 Hldgs %
29.74%
Holding
13,792
New
1,607
Increased
5,174
Reduced
5,388
Closed
1,330

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.51B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.53B
3
AMZN icon
Amazon
AMZN
+$1.11B
4
ABNB icon
Airbnb
ABNB
+$574M
5
NVDA icon
NVIDIA
NVDA
+$519M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 1.94%
2 Technology 1.9%
3 Communication Services 1.42%
4 Financials 1.08%
5 Healthcare 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATMP icon
11551
iPath Select MLP ETN
ATMP
$657M
$193K ﹤0.01%
11,691
-61,675
-84% -$955K
GTE icon
11552
PUT
Gran Tierra Energy
GTE
$357M
$193K ﹤0.01%
26,030
+13,130
+102% +$89.6K
LOKM.U
11553
DELISTED
Live Oak Mobility Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-fifth of one warrant
LOKM.U
$193K ﹤0.01%
19,184
AFI
11554
CALL
DELISTED
Armstrong Flooring, Inc.
AFI
$193K ﹤0.01%
31,200
+2,100
+7% +$12.1K
LGHL
11555
Lion Group Holding
LGHL
$514K
-1
Closed -$712K
ELOX
11556
PUT
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$192K ﹤0.01%
+2,410
New +$201K
CTSO icon
11557
CALL
Cytosorbents Corp
CTSO
$22.6M
$191K ﹤0.01%
25,300
-26,700
-51% -$225K
ENLV icon
11558
Enlivex Ltd
ENLV
$26.4M
$191K ﹤0.01%
1,433
-1,774
-55% -$267K
JOBY icon
11559
CALL
Joby Aviation
JOBY
$7.06B
$191K ﹤0.01%
19,100
-54,500
-74% -$545K
MYPS icon
11560
PUT
PLAYSTUDIOS Inc
MYPS
$59.8M
$191K ﹤0.01%
+25,700
New +$249K
SRS icon
11561
CALL
ProShares UltraShort Real Estate
SRS
$13.8M
$191K ﹤0.01%
2,900
+937
+48% +$66.4K
SYRS
11562
CALL
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$191K ﹤0.01%
3,510
-1,400
-29% -$82.9K
NBSE
11563
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$191K ﹤0.01%
1,997
-1,339
-40% -$148K
TCDA
11564
PUT
DELISTED
Tricida, Inc. Common Stock
TCDA
$191K ﹤0.01%
44,200
-8,200
-16% -$39.1K
EXTN
11565
PUT
DELISTED
Exterran Corporation
EXTN
$191K ﹤0.01%
40,200
-7,700
-16% -$33K
GPX
11566
DELISTED
GP Strategies Corp.
GPX
$191K ﹤0.01%
+12,174
New +$197K
ACTG icon
11567
PUT
Acacia Research
ACTG
$438M
$189K ﹤0.01%
28,000
-136,400
-83% -$812K
FSP
11568
Franklin Street Properties
FSP
$43.4M
$189K ﹤0.01%
35,942
-5,282
-13% -$28.3K
OSW icon
11569
OneSpaWorld
OSW
$2.69B
$189K ﹤0.01%
19,486
-5,288
-21% -$57.8K
RDI icon
11570
CALL
Reading International Class A
RDI
$44.4M
$189K ﹤0.01%
27,100
-4,600
-15% -$29.1K
PRPB
11571
PUT
DELISTED
CC Neuberger Principal Holdings II Class A Ordinary Shares
PRPB
$189K ﹤0.01%
19,100
-37,200
-66% -$369K
CLIR icon
11572
ClearSign Technologies
CLIR
$31.7M
$188K ﹤0.01%
3,921
-5,709
-59% -$270K
DX
11573
PUT
Dynex Capital
DX
$3.2B
$188K ﹤0.01%
10,100
-3,600
-26% -$70.6K
VYGR icon
11574
PUT
Voyager Therapeutics
VYGR
$213M
$188K ﹤0.01%
45,400
-106,500
-70% -$483K
QNTM
11575
CALL
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$129
$188K ﹤0.01%
1,652
-502
-23% -$58.2K

Similar funds

Jeff Yass's Q2 2021 Portfolio in Review

As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.7% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
  • Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
  • Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
  • Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
  • Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
  • Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
  • Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.